Scripps Research scientists found that combining ruxolitinib with checkpoint inhibitors may better fight cancers like Hodgkin lymphoma. Findings in @ScienceMagazine are supported by a phase I trial and preclinical models.
#ScrippsResearch #Cancer #Science #Microbiology #Immunology #Research
Негізгі бет Scientists uncover a "one-two punch" for fighting cancer
Пікірлер